Ease NHS winter pressures: persevere with your vaccination efforts this flu season

01 November 2024
Adverse event reporting, Fluenz prescribing information and Fluenz indication can be found at the end of this article

Abstract

This promotional advertorial has been created by AstraZeneca and is intended for Great British (GB) healthcare professionals only. Fluenz is indicated for prophylaxis of influenza in individuals 24 months to less than 18 years of age. The use of Fluenz should be based on official recommendations. This article focuses on the impact of the childhood flu National Immunisation Programme on children, adults, communities and the wider healthcare system, and highlights the support that Fluenz provides throughout flu season.

AstraZeneca Promotional Advertorial | Prioritise the childhood flu National Immunisation Programme to play your part in reducing NHS winter pressures

Without vaccination, approximately 1 in 5 children and 1 in 10 adults were estimated to be infected with flu each year.1 Healthy children under the age of 5 are more likely to be admitted to hospital with flu than any other age group, and are over five times more likely than those aged over 65.2 Did you know that childhood flu vaccination with Fluenz nasal spray suspension influenza vaccine (live attenuated, nasal) may lead to an ~80% reduction in primary care ILI consultations, as shown in a study of adults aged 50–70 years?*This was in areas where primary and secondary school children had been vaccinated compared with areas with no school-based vaccination.3

*ILI consultation rate per 100,000 population: 3.4 primary and secondary school programme; 17.4 no school-based vaccination (ARR, 14)  

To play your part in reducing the burden of flu, learn more about the nasal spray flu vaccine and the importance of vaccination on our promotional AstraZeneca website.

Ensure you’re fully equipped to prioritise flu protection for the children in your local area  -

  • Access resources to help run successful vaccination clinics.
    • Understand the benefits and side effects of the Fluenz nasal spray flu vaccine
    • Support vaccine uptake in your school or GP Practice
  • Familiarise yourself with the information that parents and carers may receive post-vaccination.
    • Ensure you’re fully equipped to answer any potential questions
    • Order posters to raise awareness of the free flu vaccine
  • Order supportive resources to use throughout the childhood flu National Immunisation Programme.
    • Order colourful and fun stickers to give out to children once seasonal flu vaccination is complete

Support is available throughout the flu season for you, the children in your care and their parents and carers. Discover how the childhood flu National Immunisation Programme can impact children, adults, communities and the wider healthcare system. 

Click here for GB prescribing information for Fluenz.

Fluenz is indicated for prophylaxis of influenza in children and adolescents from 24 months to less than 18 years of age. The use of Fluenz should be based on official recommendations.

________________________________________________________________________________________________________

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com or by calling 0800 783 0033. _______________________________________________________________________________________________________

Abbreviations:

ARR=absolute risk reduction; flu=influenza; GP=general practitioner; ILI=influenza-like illness; NHS=National Health Service.

References:

  1. Somes MP, et al. Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: a systematic review and meta-analysis. Vaccine. 2018;36(23): 3199-3207
  2. Cromer D, van Hoek AJ, Jit M, et al. The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy. J Infect. 2014;68(4):363-371
  3. Annual Report Chief Medical Officer 2015. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/654806/CMO_baby_boomers_annual_report_2015.pdf Accessed October 2024

GB-61870 | November 2024